|
|
Article: Actonel Significantly Reduced Osteoporotic Fractures in High-Risk Postmenopausal Women, at One Year; Risk of Spinal Fracture Reduced by Up to 62 Percent.
- Article from:
- PR Newswire
- Article date:
- February 10, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Newly published data show that treatment with 5 mg Actonel(R) (risedronate sodium tablets) daily reduced the risk of spinal fracture in postmenopausal osteoporotic patients at higher risk of fracture because of age or low bone mineral density (BMD) at the hip. In these patients, fracture risk was reduced by 62 percent and 60 percent, respectively, at one year with Actonel compared with placebo. The analysis of combined data from two studies was published in the February issue of the Journal of Clinical Endocrinology and Metabolism, and also shows that the fracture reduction benefits of Actonel in patients at higher risk of fracture were similar to the benefits observed ...